Status:
UNKNOWN
Oral Isotretinoin and Covid-19 Infection
Lead Sponsor:
University of Aberdeen
Conditions:
Isotretinoin Adverse Reaction
Covid19
Eligibility:
All Genders
16-40 years
Brief Summary
There is a theoretical risk that the nasal mucosal dryness caused by oral retinoid medications may increase the risk of patients becoming infected with Covid-19. Isotretinoin is a drug used commonly ...
Detailed Description
Isotretinoin is a drug used commonly in dermatology, usually for management of acne and occasionally for management of other dermatological diseases. The most common side effect of oral isotretinoin i...
Eligibility Criteria
Inclusion
- Test: prescribed oral isotretinoin in NHS Grampian age 16-40years includive, between March-Oct 2020
- Background control population: residing in NHS Grampian, age 16-40years, etsted for Covid-19 between march -oct 2020, not prescribed oral isotretinoin in timeframe.
Exclusion
- Test population: not prescribed oral isotretinoin in NHS grampian, outwith age range 16-40years or treatment range March-October 2020.
- Background control popuat8ion: prescribed oral isotretinoin between march-october 2020, age outwith 16-40years, not tested for covid-19 between March-Oct 2020.
Key Trial Info
Start Date :
January 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04663906
Start Date
January 15 2021
End Date
May 31 2021
Last Update
December 11 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.